Plain-English translation of NCT07512882 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Leukemia research guide →This is a research study that aims to build a large database of patients with chronic myelomonocytic leukemia — a rare type of blood cancer. Researchers will collect your blood samples and medical information at the time of your diagnosis and as your disease progresses, either with or without treatment. The goal is to help scientists learn more about this condition and improve future care.
Chronic myelomonocytic leukemia is a rare disease that researchers don't yet fully understand. By collecting samples and data from many patients over time, this study hopes to identify patterns, improve diagnosis, and develop better treatment options for people with this condition.
You likely qualify if…
You likely don't qualify if…
You will donate blood samples at the time of your diagnosis and potentially at follow-up visits as your disease progresses. These samples will be collected during routine care visits or as part of other clinical trials you may be in — no extra visits are required. Your anonymized medical information will also be stored in a research database to help scientists study the disease over time.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
France